NM_020987.5:c.115-45940A>G
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_020987.5(ANK3):c.115-45940A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.709 in 151,992 control chromosomes in the GnomAD database, including 38,780 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.71   (  38780   hom.,  cov: 31) 
Consequence
 ANK3
NM_020987.5 intron
NM_020987.5 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  -0.00500  
Publications
37 publications found 
Genes affected
 ANK3  (HGNC:494):  (ankyrin 3) Ankyrins are a family of proteins that are believed to link the integral membrane proteins to the underlying spectrin-actin cytoskeleton and play key roles in activities such as cell motility, activation, proliferation, contact, and the maintenance of specialized membrane domains. Multiple isoforms of ankyrin with different affinities for various target proteins are expressed in a tissue-specific, developmentally regulated manner. Most ankyrins are typically composed of three structural domains: an amino-terminal domain containing multiple ankyrin repeats; a central region with a highly conserved spectrin binding domain; and a carboxy-terminal regulatory domain which is the least conserved and subject to variation. Ankyrin 3 is an immunologically distinct gene product from ankyrins 1 and 2, and was originally found at the axonal initial segment and nodes of Ranvier of neurons in the central and peripheral nervous systems. Multiple transcript variants encoding different isoforms have been found for this gene.[provided by RefSeq, Feb 2011] 
ANK3 Gene-Disease associations (from GenCC):
- intellectual disability-hypotonia-spasticity-sleep disorder syndromeInheritance: AR Classification: STRONG, SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
 - intellectual disabilityInheritance: AR, AD Classification: MODERATE, LIMITED Submitted by: ClinGen, Ambry Genetics
 - Tourette syndromeInheritance: Unknown Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89). 
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.882  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| ANK3 | NM_020987.5  | c.115-45940A>G | intron_variant | Intron 1 of 43 | ENST00000280772.7 | NP_066267.2 | ||
| ANK3 | NM_001204404.2  | c.64-45940A>G | intron_variant | Intron 1 of 43 | NP_001191333.1 | |||
| ANK3 | NM_001320874.2  | c.115-45940A>G | intron_variant | Intron 1 of 42 | NP_001307803.1 | |||
| ANK3 | NM_001204403.2  | c.97-45940A>G | intron_variant | Intron 2 of 43 | NP_001191332.1 | 
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.709  AC: 107675AN: 151874Hom.:  38765  Cov.: 31 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
107675
AN: 
151874
Hom.: 
Cov.: 
31
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome   AF:  0.709  AC: 107730AN: 151992Hom.:  38780  Cov.: 31 AF XY:  0.712  AC XY: 52865AN XY: 74290 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
107730
AN: 
151992
Hom.: 
Cov.: 
31
 AF XY: 
AC XY: 
52865
AN XY: 
74290
show subpopulations 
African (AFR) 
 AF: 
AC: 
23789
AN: 
41428
American (AMR) 
 AF: 
AC: 
11322
AN: 
15284
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
2726
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
3705
AN: 
5146
South Asian (SAS) 
 AF: 
AC: 
4343
AN: 
4804
European-Finnish (FIN) 
 AF: 
AC: 
7443
AN: 
10572
Middle Eastern (MID) 
 AF: 
AC: 
229
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
51990
AN: 
67976
Other (OTH) 
 AF: 
AC: 
1558
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.501 
Heterozygous variant carriers
 0 
 1568 
 3136 
 4705 
 6273 
 7841 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 832 
 1664 
 2496 
 3328 
 4160 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
2699
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.